These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23710206)

  • 21. Thymus-derived rather than tumor-induced regulatory T cells predominate in brain tumors.
    Wainwright DA; Sengupta S; Han Y; Lesniak MS
    Neuro Oncol; 2011 Dec; 13(12):1308-23. PubMed ID: 21908444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratumoral depletion of regulatory T cells using CD25-targeted photodynamic therapy in a mouse melanoma model induces antitumoral immune responses.
    Oh DS; Kim H; Oh JE; Jung HE; Lee YS; Park JH; Lee HK
    Oncotarget; 2017 Jul; 8(29):47440-47453. PubMed ID: 28537894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two distinct mechanisms of augmented antitumor activity by modulation of immunostimulatory/inhibitory signals.
    Mitsui J; Nishikawa H; Muraoka D; Wang L; Noguchi T; Sato E; Kondo S; Allison JP; Sakaguchi S; Old LJ; Kato T; Shiku H
    Clin Cancer Res; 2010 May; 16(10):2781-91. PubMed ID: 20460483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
    Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
    Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes.
    Setiady YY; Coccia JA; Park PU
    Eur J Immunol; 2010 Mar; 40(3):780-6. PubMed ID: 20039297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
    Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of regulatory T cells in malignant glioma.
    Sonabend AM; Rolle CE; Lesniak MS
    Anticancer Res; 2008; 28(2B):1143-50. PubMed ID: 18505050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient Treg depletion induces T-cell infiltration and rejection of large tumors.
    Li X; Kostareli E; Suffner J; Garbi N; Hämmerling GJ
    Eur J Immunol; 2010 Dec; 40(12):3325-35. PubMed ID: 21072887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of PD-1 upregulation on tumor-infiltrating lymphocytes in human and murine gliomas and preclinical therapeutic blockade.
    Dejaegher J; Verschuere T; Vercalsteren E; Boon L; Cremer J; Sciot R; Van Gool SW; De Vleeschouwer S
    Int J Cancer; 2017 Nov; 141(9):1891-1900. PubMed ID: 28681455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b
    Ramezani-Aliakbari K; Khaki-Bakhtiarvand V; Mahmoudian J; Asgarian-Omran H; Shokri F; Hojjat-Farsangi M; Jeddi-Tehrani M; Shabani M
    Int Immunopharmacol; 2023 Aug; 121():110463. PubMed ID: 37327513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
    Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
    Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
    Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
    Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.
    Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D
    Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535
    [No Abstract]   [Full Text] [Related]  

  • 34. CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model.
    Jordan M; Waxman DJ
    Cancer Lett; 2016 Apr; 373(1):88-96. PubMed ID: 26655275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Temozolomide combined with PD-1 Antibody therapy for mouse orthotopic glioma model.
    Dai B; Qi N; Li J; Zhang G
    Biochem Biophys Res Commun; 2018 Jul; 501(4):871-876. PubMed ID: 29758196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CCR2 and CCR5 co-inhibition modulates immunosuppressive myeloid milieu in glioma and synergizes with anti-PD-1 therapy.
    Pant A; Hwa-Lin Bergsneider B; Srivastava S; Kim T; Jain A; Bom S; Shah P; Kannapadi N; Patel K; Choi J; Cho KB; Verma R; Yu-Ju Wu C; Brem H; Tyler B; Pardoll DM; Jackson C; Lim M
    Oncoimmunology; 2024; 13(1):2338965. PubMed ID: 38590799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells.
    Varga G; Ehrchen J; Tsianakas A; Tenbrock K; Rattenholl A; Seeliger S; Mack M; Roth J; Sunderkoetter C
    J Leukoc Biol; 2008 Sep; 84(3):644-50. PubMed ID: 18611985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines.
    Ueda R; Fujita M; Zhu X; Sasaki K; Kastenhuber ER; Kohanbash G; McDonald HA; Harper J; Lonning S; Okada H
    Clin Cancer Res; 2009 Nov; 15(21):6551-9. PubMed ID: 19861464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study.
    Badie B; Schartner JM; Paul J; Bartley BA; Vorpahl J; Preston JK
    J Neurosurg; 2000 Oct; 93(4):634-9. PubMed ID: 11014542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model.
    Chirasani SR; Leukel P; Gottfried E; Hochrein J; Stadler K; Neumann B; Oefner PJ; Gronwald W; Bogdahn U; Hau P; Kreutz M; Grauer OM
    Int J Cancer; 2013 Feb; 132(4):843-53. PubMed ID: 22752934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.